The coronavirus variant detected in South Africa poses a “significant re-infection risk” and raises concerns over vaccine effectiveness, according to preliminary research Wednesday, as separate
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
